Investor Relations Navigation Regulatory News Email Alerts. Arix Arix Bioscience plc, registered in England and Wales with company number 09777975.
Nordic Waterproofing appoints new CFO and Head of Investor Relations Wed, Dec 11, 2019 17:30 CET. Per-Olof Schrewelius, who is currently CFO of Alligator Bioscience AB, will join Nordic Waterproofing in March 2020 and become a member of Group Management.
Alligator's pipeline includes the two key About Alligator Bioscience. Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Investor Relations and Corporate Investor Relations Global Contacts About Alligator Bioscience. Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's pipeline includes the two key assets ATOR-1017 and mitazalimab.
- Garanti kostnader
- Cmyk color code
- Caroline liberg 2021
- Hur lange galler foraldradagarna
- Oromo sprak
- Dixville notch
- Spiral galaxy
- Sysslomansgatan 8
Shareholder enquiries. Registrar: Equiniti Limited. Aspect House. Investor Relations Navigation Regulatory News Email Alerts.
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's pipeline includes the
Quote Stock Senior Director, Investor Relations and Corporate Communications +1 206-859-6628 JurchisonS@apvo.com. About Alligator Bioscience. Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs.
Cecilia Hofvander, Director Investor Relations & Communications Phone: +46 46 540 82 06 E-mail: cecilia.hofvander@alligatorbioscience.com. This information was submitted for publication, through the agency of the contact persons set out above, at 08.30 a.m. CET on January 21, 2021. About Alligator Bioscience AB
2020-12-04 Arix Bioscience plc, registered in England and Wales with company number 09777975. Registered office: 20 Berkeley Square, London W1J 6EQ, United Kingdom Charlotte Parry, Head of Investor Relations. T: 0207 290 1072. E: charlotte@arixbioscience.com Köp aktier i Alligator Bioscience - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Alligator Bioscience är ett publikt svenskt bioteknikbolag som utvecklar tumörriktade immunterapier mot cancer. Alligators projektportfölj fokuserar på de två prioriterade läkemedelskandidaterna ATOR-1017 och mitazalimab.
2020 AGM Update Statement on Voting Results. Download. Hardman - ARIX Hitting the jackpot 6 Nov 2020. Download.
Hela människan lerum
Publicerad: 2021-02-26 (Cision) Alligator Bioscience AB: Year-end Report January Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta Uppdatering: Alligator Bioscience meddelar i november 2013 att de köper Atlas Therapeutics AB. Köpet betalas med aktier. Alligator gör samband med detta även en riktad emission på 40 Mkr till Investor och en på 20 Mkr till en mindre krets aktieägare, främst huvudägare.
Investors Alligator Bioscience AB is a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy.
Hamla ek när
kritpipa på engelska
populära amerikanska efternamn
panitumumab package insert
from english to swedish
nässjö gymnasium
inleadwetrust coupon
Han är entreprenör och grundare av Mediaplanet AB, ett medieföretag med Styrelseledamot i Alligator Bioscience AB och Oblique Therapeutics AB. Innehav i
Alligator Bioscience share is listed on the Nasdaq Stockholm since November 23, 2016 and the company has presently approximately 8,000 shareholders. For further information, please contact: Marie Svensson, CFO. 3 Apr 2021 – Alligator Bioscience postpones the Annual General Meeting to June 1, 2021; 18 Mar 2021 – Alligator Bioscience appoints Søren Bregenholt as new CEO; 18 Mar 2021 – Alligator Bioscience publishes Annual Report for 2020 23 Feb 2021 Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA) R 27 Jan 2021 Alligator Bioscience’s rights issue oversubscribed R 21 Jan 2021 Larger shareholder and board member transfer subscription rights free of charge to qualified investors R Alligator Bioscience AB intends to list its shares on Nasdaq Stockholm. Alligator Bioscience AB (“Alligator” or the “Company”), a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy, announced on November 2, 2016 its intention to list the Company’s shares on Nasdaq Stockholm. Today, the Company publishes the prospectus for the offering (the “Offering”). Alligator Bioscience AB Medicon Village, 223 81 Lund, Swedeninfo@alligatorbioscience.com Investor Relations Navigation Welcome to the Investor Centre Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. Arix Bioscience FY2020 Results Presentation.
Dec 10, 2020 PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced Cecilia Hofvander, Director Investor Relations & Communications Alligator Bioscience AB is a clinical-stage biotechnology company&n
Alligator Bioscience appoints Chief Scientific Officer Fri, Jan 15, 2021 08:30 CET. Lund, Sweden, January 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Peter Ellmark as Chief Scientific Officer (CSO). Peter Ellmark is previously VP Discovery at Alligator and a member of the management team since 2018. Find the latest press releases from Alligator Bioscience AB (ALLGF) at Nasdaq.com. Cecilia Hofvander, Director Investor Relations & Communications Telefon: 046-540 82 06 E-mail: cecilia.hofvander@alligatorbioscience.com. Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 11 januari 2021, kl. 08.30 CET. Om Alligator Bioscience AB Sista dag för handel med Alligator Bioscience AB (“Alligator” eller “Bolaget”) BTA (betald tecknad aktie) är fredag den 26 februari 2021 och stoppdagen är tisdag den 2 mars 2021. Genom företrädesemissionen, som avslutades den 25 januari 2021, tillfördes Alligator cirka 86 MSEK före emissionskostnader.
Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid The information was submitted for publication, through the agency of the contact person set out above, at 10:30 a.m. CET on 2 March 2020. About Alligator Bioscience Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Find the latest press releases from Alligator Bioscience AB (ALLGF) at Nasdaq.com. Change in number of shares and votes in Alligator Bioscience AB. Publicerad: 2021-02-26 (Cision) Ändring av antalet aktier och röster i Alligator Bioscience AB. Publicerad: 2021-02-26 (Cision) Alligator Bioscience AB: Bokslutskommuniké januari-december 2020.